In our MI-RISK consortium, consisting of 4 internationally recognized research groups, it is our ambition to bridge the knowledge gap between AMI and SCD to improve survival of AMI patients. Inclusion of complementary research groups with expertise’s spanning from patient to animal model to molecular biology to computer simulation underpins a synergistic approach to discover risk factors and causes of SCD during AMI.





Jacob Tfelt-Hansen,Clinical Research Associate Professor, Staff Cardiologist, DMSc, Department of Cardiology,
Copenhagen University Hospital, Rigshospitalet


Thomas Jespersen, Associate Professor, PhD, DMSc,Department of Biomedical Sciences, University of Copenhagen



Christine M. Albert Director of the Center for Arrhythmia Prevention at the Brigham and Women’s Hospital and Professor at Harvard Medical School


Molly Maleckar Director of the Simula School of Research and Innovation at Simula Research Laboaratory






Funded by Novo Nordic foundation